Akebia Therapeutics (AKBA) Other Non-Current Liabilities (2013 - 2026)
Akebia Therapeutics (AKBA) posted Other Non-Current Liabilities of $2 million for Q2 2026, down 85.9% from $14.2 million a year earlier and down 20.8% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Akebia Therapeutics' Other Non-Current Liabilities came in at $3 million, down 42.3% from FY2024.
- Annual Other Non-Current Liabilities has declined for four consecutive years, with a five-year compound annual growth rate of -45.2% (FY2020 to FY2025).
- In prior years, Akebia Therapeutics' Other Non-Current Liabilities was $5.2 million in FY2024 (-41.5%), $8.89 million in FY2023 (-43.5%), $15.72 million in FY2022 (-81.3%) and $84.21 million in FY2021 (+38.9%).
- The Q2 2026 figure stands as the lowest quarterly Other Non-Current Liabilities since Q2 2016.
- On a year-over-year basis, Other Non-Current Liabilities has declined in each of the last three quarters, with an average decline of 18.8% over the last eight quarters.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q2 2025, with growth of 116.6%; the weakest was Q3 2023, with a decline of 88.7%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $2.52 million (Q1 2026), $3 million (Q4 2025) and $5.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Akebia Therapeutics | 157.80 Mn | -511.68 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.52 Mn |
| Mar 31, 2026 | 5.73 Mn |
| Dec 31, 2025 | 7.80 Mn |
| Sep 30, 2025 | 15.44 Mn |
| Jun 30, 2025 | 33.75 Mn |
| Mar 31, 2025 | 19.53 Mn |
| Dec 31, 2024 | 15.13 Mn |
| Sep 30, 2024 | 11.73 Mn |
| Jun 30, 2024 | 11.80 Mn |
| Mar 31, 2024 | 16.75 Mn |
| Dec 31, 2023 | 8.89 Mn |
| Sep 30, 2023 | 10.18 Mn |
| Jun 30, 2023 | 17.90 Mn |
| Mar 31, 2023 | 16.77 Mn |
| Dec 31, 2022 | 16.48 Mn |
| Sep 30, 2022 | 83.10 Mn |
| Jun 30, 2022 | 74.61 Mn |
| Mar 31, 2022 | 83.14 Mn |
| Dec 31, 2021 | 86.03 Mn |
| Sep 30, 2021 | 79.32 Mn |
API Access
Akebia Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();